Karin E. Smedby

13.9k total citations · 1 hit paper
206 papers, 5.8k citations indexed

About

Karin E. Smedby is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics. According to data from OpenAlex, Karin E. Smedby has authored 206 papers receiving a total of 5.8k indexed citations (citations by other indexed papers that have themselves been cited), including 106 papers in Pathology and Forensic Medicine, 87 papers in Oncology and 45 papers in Genetics. Recurrent topics in Karin E. Smedby's work include Lymphoma Diagnosis and Treatment (99 papers), Chronic Lymphocytic Leukemia Research (39 papers) and Viral-associated cancers and disorders (31 papers). Karin E. Smedby is often cited by papers focused on Lymphoma Diagnosis and Treatment (99 papers), Chronic Lymphocytic Leukemia Research (39 papers) and Viral-associated cancers and disorders (31 papers). Karin E. Smedby collaborates with scholars based in Sweden, Denmark and United States. Karin E. Smedby's co-authors include Henrik Hjalgrim, Johan Askling, Hans‐Olov Adami, Eva Baecklund, Ellen T. Chang, Mads Melbye, Sandra Eloranta, Christer Sundström, Bengt Glimelius and Ingrid Glimelius and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Karin E. Smedby

198 papers receiving 5.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Adaptation of the Charlson Comorbidity Index for Register-Based Research in Sweden

2021 169 citations Johan Askling, Karin E. Smedby et al. profile →

Peers

Countries citing papers authored by Karin E. Smedby

Since Specialization

Citations

This map shows the geographic impact of Karin E. Smedby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karin E. Smedby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karin E. Smedby more than expected).

Fields of papers citing papers by Karin E. Smedby

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karin E. Smedby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karin E. Smedby. The network helps show where Karin E. Smedby may publish in the future.

Co-authorship network of co-authors of Karin E. Smedby

This figure shows the co-authorship network connecting the top 25 collaborators of Karin E. Smedby. A scholar is included among the top collaborators of Karin E. Smedby based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karin E. Smedby. Karin E. Smedby is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Association of Pre‐Diagnostic Clonal Hematopoiesis of Indeterminate Potential With Prognosis Among Patients With Cancer 2025 ·American Journal of Hematology ·(unknown), Hans‐Olov Adami, Tove Wästerlid, (unknown), (unknown), Karin E. Smedby, Fang Fang, Qianwei Liu	0
2	Infections in patients with mantle cell lymphoma 2024 ·HemaSphere ·Kossi Abalo, Sara Ekberg, Therése Andersson, (unknown), (unknown), Karin E. Smedby, Mats Jerkeman, Ingrid Glimelius	4
3	Effectiveness of R‐CHOP versus R‐CHOEP for treatment of young patients with high‐risk diffuse large B‐cell lymphoma: A Danish observational population‐based study 2024 ·European Journal Of Haematology ·(unknown), Lasse Jakobsen, Sandra Eloranta, Karin E. Smedby, Robert Schou Pedersen, Judit Jørgensen, Michael Roost Clausen, Peter de Nully Brown, Anne Ortved Gang, (unknown), Thomas Stauffer Larsen, Mats Jerkeman, Tarec Christoffer El‐Galaly	2
4	Risk and mortality of testicular cancer in patients with neurodevelopmental or other psychiatric disorders 2023 ·British Journal of Cancer ·(unknown), Jonas Söderling, Johan Reutfors, (unknown), Camilla Sköld, Gabriella Cohn‐Cedermark, Olof Ståhl, Karin E. Smedby, Andreas Pettersson, Ingrid Glimelius	4
5	Potential for Cure by Stage across the Cancer Spectrum in the United States 2023 ·Cancer Epidemiology Biomarkers & Prevention ·Earl Hubbell, Christina A. Clarke, Karin E. Smedby, Hans‐Olov Adami, Ellen T. Chang	3
6	Prevalence and predictors for fertility-related distress among 1010 young adults 1.5 years following cancer diagnosis – results from the population-based Fex-Can Cohort study 2023 ·Acta Oncologica ·Kenny A. Rodriguez‐Wallberg, Johan Ahlgren, Karin E. Smedby, Jessica R. Gorman, Kristina Hellman, Roger Henriksson, Olof Ståhl, Lena Wettergren, Claudia Lampic	9
7	Outcomes of relapsed/refractory diffuse large B‐cell lymphoma and influence of chimaeric antigen receptor T trial eligibility criteria in second line—A population‐based study of 736 patients 2022 ·British Journal of Haematology ·(unknown), Sandra Eloranta, Sara Ekberg, Gunilla Enblad, Tarec Christoffer El‐Galaly, Birgitta Sander, Kristina Sonnevi, Per‐Ola Andersson, Mats Jerkeman, Karin E. Smedby	20
8	Patient trajectories after diagnosis of diffuse large B-cell lymphoma—a multistate modelling approach to estimate the chance of lasting remission 2022 ·British Journal of Cancer ·Sara Ekberg, Michael J. Crowther, (unknown), Mats Jerkeman, Karin E. Smedby, Sandra Eloranta	2
9	Late effects in patients with mantle cell lymphoma treated with or without autologous stem cell transplantation 2022 ·Blood Advances ·Sara Ekberg, Karin E. Smedby, (unknown), Mats Jerkeman, Caroline E. Weibull, Ingrid Glimelius	5
10	Risk of diabetes and the impact on preexisting diabetes in patients with lymphoma treated with steroid-containing immunochemotherapy 2022 ·Blood Advances ·Joachim Bæch, Marianne Tang Severinsen, (unknown), Henrik Frederiksen, Peter Vestergaard, Christian Torp‐Pedersen, Judit Jørgensen, Michael Roost Clausen, Christian Bjørn Poulsen, Peter de Nully Brown, Anne Ortved Gang, Robert Schou Pedersen, Karin E. Smedby, Sandra Eloranta, Lasse Jakobsen, Tarec Christoffer El‐Galaly	2
11	Parenthood Rates and Use of Assisted Reproductive Techniques in Younger Hodgkin Lymphoma Survivors: A Danish Population-Based Study 2021 ·Journal of Clinical Oncology ·(unknown), Lasse Hjort Jakobsen, Sandra Eloranta, Kristian Kragholm, Martin Hutchings, Henrik Frederiksen, Peter Kamper, (unknown), (unknown), Caroline E. Weibull, (unknown), Ingrid Glimelius, Karin E. Smedby, Christian Torp‐Pedersen, Marianne Tang Severinsen, Tarec Christoffer El‐Galaly	14
12	Lymphoma risks in patients with rheumatoid arthritis treated with biological drugs—a Swedish cohort study of risks by time, drug and lymphoma subtype 2020 ·Lara D. Veeken ·Karin Hellgren, Daniela Di Giuseppe, Karin E. Smedby, Christer Sundström, Johan Askling, Eva Baecklund, (unknown)	27
13	Statin use is associated with improved survival in multiple myeloma: A Swedish population‐based study of 4315 patients 2020 ·American Journal of Hematology ·(unknown), Sara Ekberg, Sandra Eloranta, Tove Wästerlid, Brenda M. Birmann, Karin E. Smedby	26
14	Risk of Ischemic Stroke and Major Bleeding in Patients with Atrial Fibrillation and Cancer 2019 ·Journal of Stroke and Cerebrovascular Diseases ·Sara Aspberg, Liyang Yu, Bruna Gigante, Karin E. Smedby, Daniel E. Singer	20
15	Evaluation of the antibody response to the EBV proteome in EBV‐associated classical Hodgkin lymphoma 2019 ·International Journal of Cancer ·Zhiwei Liu, Ruth F. Jarrett, Henrik Hjalgrim, Carla Proietti, Ellen T. Chang, Karin E. Smedby, Kelly J. Yu, Annette Lake, (unknown), Karen A. McAulay, Ruth M. Pfeiffer, Hans‐Olov Adami, Bengt Glimelius, Mads Melbye, Allan Hildesheim, Denise L. Doolan, Anna E. Coghill	12
16	Beta-Blocker Drug Use and Survival among Patients with Pancreatic Adenocarcinoma 2017 ·Cancer Research ·Ruzan Udumyan, Scott Montgomery, Fang Fang, Henrik Almroth, Unnur Valdimarsdóttir, Anders Ekbom, Karin E. Smedby, Katja Fall	76
17	Work Loss Duration and Predictors Following Rectal Cancer Treatment among Patients with and without Prediagnostic Work Loss 2016 ·Cancer Epidemiology Biomarkers & Prevention ·Lingjing Chen, Ingrid Glimelius, Martin Neovius, Sara Ekberg, Anna Martling, Sandra Eloranta, Karin E. Smedby	11
18	Association Between Long-term Oral Contraceptive Use and Risk of Crohn’s Disease Complications in a Nationwide Study 2016 ·Gastroenterology ·Hamed Khalili, Fredrik Granath, Karin E. Smedby, Anders Ekbom, Martin Neovius, Andrew T. Chan, Ola Olén	45
19	Borrelia infection and risk of non-Hodgkin lymphoma 2008 ·Blood ·Claudia Schöllkopf, Mads Melbye, Lars Munksgaard, Karin E. Smedby, Klaus Rostgaard, Bengt Glimelius, Ellen T. Chang, Göran Roos, Mads Hansen, Hans‐Olov Adami, Henrik Hjalgrim	63
20	Serum YKL-40 and interleukin 6 levels in Hodgkin lymphoma 2008 ·QUT ePrints (Queensland University of Technology) ·Robert J. Biggar, Julia S. Johansen, Karin E. Smedby, Klaus Rostgaard, Ellen T. Chang, Hans‐Olov Adami, Bengt Glimelius, Daniel Molin, Stephen Hamilton‐Dutoit, Mads Melbye, Henrik Hjalgrim	52

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact